Tysabri Home Infusion: Navigating the TOUCH Program and What It Means for Patients

Tysabri (natalizumab) is one of the most effective treatments for relapsing multiple sclerosis, but receiving it at home is more complicated than with most other biologics. The mandatory TOUCH Prescribing Program adds layers of registration, monitoring, and pharmacy certification that patients must understand before pursuing home infusion. Here is what that process actually involves — and where the real obstacles lie.

What the TOUCH Program Requires

The TOUCH (Tysabri Outreach: Unified Commitment to Health) Prescribing Program is an FDA-mandated Risk Evaluation and Mitigation Strategy (REMS). It exists because Tysabri carries a risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection caused by the JC virus. Every patient, prescriber, infusion center, and pharmacy involved in Tysabri treatment must be enrolled in TOUCH.

For home infusion specifically, the TOUCH requirements include:

• Patient enrollment: Patients must complete and sign a TOUCH enrollment form acknowledging the risks of PML, and must re-authorize every 6 months.
• Prescriber certification: The neurologist must be registered with the TOUCH program and must complete prescribing authorization before each infusion cycle.
• Pharmacy and infusion site certification: The home infusion pharmacy dispensing and the nurse administering Tysabri must both be TOUCH-certified. Not all home infusion pharmacies carry this certification.
• Pre-infusion questionnaire: Before every infusion, patients must answer screening questions about new neurological symptoms that could indicate PML.

Finding a Certified Home Infusion Pharmacy

This is where many patients hit an unexpected wall. Unlike Remicade or Entyvio, which can be dispensed by virtually any licensed home infusion pharmacy, Tysabri requires the pharmacy to hold specific TOUCH certification. The pool of eligible pharmacies is smaller, and in some geographic areas, options may be limited.

When evaluating a home infusion pharmacy for Tysabri, patients should confirm:

• The pharmacy is TOUCH-certified and currently active in the program
• The nurses the pharmacy dispatches are individually TOUCH-certified
• The pharmacy is in the patient’s insurance network
• The pharmacy has experience specifically with Tysabri home infusion (not just general biologics)

A common frustration: a patient’s preferred home infusion pharmacy may handle dozens of other biologics but lack TOUCH certification. Switching pharmacies solely for Tysabri can create administrative complications with insurance and care coordination.

JC Virus Monitoring at Home

JC virus antibody testing is a cornerstone of Tysabri safety monitoring. Patients receive blood tests — typically every 6 months — to check for JC virus antibody status. A positive result does not necessarily mean Tysabri must be stopped, but it changes the risk calculus significantly, particularly for patients who have been on Tysabri for more than 2 years.

For patients receiving Tysabri at home, the JC virus monitoring adds a logistical layer. The blood draw for antibody testing needs to happen at regular intervals, and this requires coordination between the neurologist, the lab, and the home infusion team. Some approaches include:

• The home infusion nurse draws labs during an infusion visit, which is efficient but requires standing lab orders
• The patient visits a local lab separately for blood draws
• Mobile phlebotomy services are arranged through the home infusion pharmacy

According to the National MS Society, patients who are JC virus antibody positive — especially those with an antibody index above 1.5 who have been on Tysabri for over 2 years or have prior immunosuppressant use — face the highest PML risk. These patients require the most vigilant monitoring regardless of infusion setting.

A subtlety that clinic patients may take for granted: in a medical office, MRI scheduling reminders and lab result follow-ups are often built into the workflow. At home, patients may need to be more proactive in ensuring these monitoring steps happen on schedule. Keeping a personal calendar of due dates for JC virus testing and brain MRIs is a practical safeguard.

What Infusion Day Looks Like

The Tysabri infusion itself is relatively straightforward compared to its regulatory overhead. Here is the typical protocol:

1. Pre-infusion screening: The nurse completes the required TOUCH questionnaire with the patient, verifying no new or worsening neurological symptoms
2. Vitals check: Blood pressure, temperature, and pulse are recorded
3. Infusion: Tysabri is infused intravenously over approximately 1 hour
4. Post-infusion observation: The patient must be observed for 1 hour after the infusion ends — this is a TOUCH program requirement, not optional

Total appointment time runs approximately 2.5 to 3 hours including setup and documentation. Premedication is not routinely required for Tysabri, though individual prescribers may order it for patients who have experienced mild reactions.

Weighing the Decision

Tysabri home infusion is achievable but demands more advance planning than home infusion of most other biologics. Patients should weigh several factors:

For patients with mobility challenges from MS, or those who live far from a certified infusion center, the convenience gains of home infusion can be substantial despite the added administrative complexity. Patients exploring MS home infusion options more broadly may want to compare how different MS treatments align with their priorities. The broader comparison of home infusion versus infusion centers also provides useful context for this decision.